The novel CXCR4 antagonist, KRH-3955 is an orally bioavailable and extremely potent inhibitor of human immunodeficiency virustype 1 infection : comparative studies with AMD3100
書誌事項
- タイトル
- The novel CXCR4 antagonist, KRH-3955 is an orally bioavailable and extremely potent inhibitor of human immunodeficiency virustype 1 infection : comparative studies with AMD3100
- 著者
- Tsutomu Murakami
収録刊行物
-
- Antimicrobial Agents and Chemotherapy 53(7)
-
Antimicrobial Agents and Chemotherapy 53(7) 2940-2948, 2009